Clinical Trial Update: The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 trial update on combining aprepitant with ondansetron to prevent postoperative nausea and vomiting in high-risk patients. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• Ondansetron (ondansetron)

Snippet

Sponsor: Yonsei University | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: COMPLETED